DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average – Here’s Why

DarioHealth Corp. (NASDAQ:DRIO)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.80 and traded as low as $0.60. DarioHealth shares last traded at $0.66, with a volume of 354,314 shares trading hands.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Stifel Nicolaus lowered their price target on DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, March 11th. TD Cowen cut shares of DarioHealth from a “buy” rating to a “hold” rating and decreased their price target for the company from $2.00 to $1.00 in a report on Wednesday, January 29th.

DarioHealth Stock Performance

The firm has a market cap of $27.26 million, a P/E ratio of -0.70 and a beta of 1.42. The stock’s 50 day moving average is $0.67 and its two-hundred day moving average is $0.80. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32.

Hedge Funds Weigh In On DarioHealth

Several institutional investors have recently added to or reduced their stakes in the company. XTX Topco Ltd lifted its position in shares of DarioHealth by 81.4% during the third quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after purchasing an additional 13,219 shares in the last quarter. DLK Investment Management LLC boosted its stake in DarioHealth by 40.9% in the 4th quarter. DLK Investment Management LLC now owns 141,657 shares of the company’s stock worth $111,000 after purchasing an additional 41,107 shares during the period. Finally, Appian Way Asset Management LP boosted its position in DarioHealth by 2.5% during the 3rd quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after acquiring an additional 34,990 shares during the last quarter. 33.39% of the stock is owned by institutional investors.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.